The Efficacy of Testosterone Ointment on Insulin Resistance in Men with Metabolic Syndrome
| Autor: | Hajime Ueshiba |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Waist business.industry Type 2 Diabetes Mellitus 030209 endocrinology & metabolism Testosterone (patch) medicine.disease 03 medical and health sciences 0302 clinical medicine Endocrinology Insulin resistance Internal medicine medicine 030212 general & internal medicine Metabolic syndrome business Homeostasis Glycemic Transdermal |
| Zdroj: | Journal of Metabolic Syndrome. |
| ISSN: | 2167-0943 |
| DOI: | 10.4172/2167-0943.1000225 |
| Popis: | Low levels of testosterone are related with metabolic syndrome and type 2 diabetes mellitus. Testosterone levels are considered to be negatively correlated with insulin resistance and HbA1c levels. There are also reports that testosterone replacement therapy reduces insulin resistance or improves glycemic control. Transdermal administration of testosterone ointment (Glowmin) is a method of drug administration that keeps blood concentrations stable and constant. In this study, testosterone ointment (Glowmin) was administrated as a testosterone supplement to male metabolic syndrome with low free testosterone levels. This study included 5 male metabolic syndrome with low free testosterone levels (mean age, 50.6 ± 8.8 years; mean BMI, 29.5 ± 3.1 kg/m2; mean waist circumference, 97 ± 7 cm; free testosterone levels |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|